Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 5 (2008), Issue 3 (March)

1. Human papillomavirus and mutated H-ras oncogene in cervical carcinomas and pathological negative pelvic lymph nodes: a retrospective follow-up.
   J Med Virol, 80(4): 694-701. [Abstract] [Full-text]
2. Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.
   J Natl Cancer Inst, 100(5): 308-20. [Abstract] [Full-text]
3. Immunohistochemical detection of the X-linked inhibitor of apoptosis protein (XIAP) in cervical squamous intraepithelial neoplasia and squamous carcinoma.
   Ann Diagn Pathol, 12(2): 85-9. [Abstract] [Full-text]
4. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts.
   Oncogene, 27(11): 1610-7. [Abstract] [Full-text]
5. Detection of human papillomavirus genotypes with liquid bead microarray in cervical lesions of northern Chinese patients.
   Cancer Genet Cytogenet, 182(1): 12-7. [Abstract] [Full-text]
6. A cost comparison of two strategies for treating stage IB2 cervical cancer.
   Int J Gynecol Cancer, 18(2): 274-8. [Abstract] [Full-text]
7. LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking.
   Int J Gynecol Cancer, 18(2): 312-7. [Abstract] [Full-text]
8. Distribution and clinical significance of human papillomavirus subtypes in Shenzhen city, People's Republic of China.
   Int J Gynecol Cancer, 18(2): 295-9. [Abstract] [Full-text]
9. Increased expression of Toll-like receptor 5 during progression of cervical neoplasia.
   Int J Gynecol Cancer, 18(2): 300-5. [Abstract] [Full-text]
10. Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women.
    Int J Gynecol Cancer, 18(2): 285-94. [Abstract] [Full-text]
11. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer.
    BJOG, 115(5): 633-8. [Abstract] [Full-text]
12. Therapeutic human papillomavirus vaccines: current clinical trials and future directions.
    Expert Opin Biol Ther, 8(4): 421-39. [Abstract] [Full-text]
13. Outcome analysis of 4 years' follow-up of patients referred for colposcopy with one smear showing mild dyskaryosis.
    Cytopathology, 19(2): 94-105. [Abstract] [Full-text]
14. Age trends in pre-cancerous and cancerous lesions of the uterine cervix in a cytology screening programme: what should be the target age group for a major thrust of screening in resource-limited settings?
    Cytopathology, 19(2): 106-10. [Abstract] [Full-text]
15. Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study.
    Int J Cancer, 122(10): 2294-300. [Abstract] [Full-text]
16. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis.
    CMAJ, 178(7): 855-62. [Abstract] [Full-text]
17. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
    Gynecol Oncol, 109(1): 49-52. [Abstract] [Full-text]
18. Cyclooxygenase-2 in cervical neoplasia: a review.
    Gynecol Oncol, 109(1): 140-5. [Abstract] [Full-text]
19. Pelvic lymph node dissection via a lateral extraperitoneal approach: description of a technique.
    Gynecol Oncol, 109(1): 81-5. [Abstract] [Full-text]
20. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
    Gynecol Oncol, 109(1): 59-64. [Abstract] [Full-text]
21. An evaluation of cervical cancer in women age sixty and over.
    Gynecol Oncol, 109(1): 53-8. [Abstract] [Full-text]
22. Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy.
    Gynecol Oncol, 109(1): 43-8. [Abstract] [Full-text]
23. Evidence of HPV16 integration in low- and high-grade cervical lesions that regress demonstrated by multiple displacement amplification and Southern blot hybridisation.
    J Clin Pathol, 61(4): 541-3. [Abstract] [Full-text]

© 2004-2008 Cervical Cancer Research Today. All Rights Reserved.